Skip to main content
Home

Main navigation

  • Top stories
  • Health
  • Crime
  • Politics
  • Business
  • Tech
  • Culture
  • Sports
  • Weird
  • 1-1-2
Image
AstraZeneca logo on a building.
AstraZeneca logo on a building. - Credit: ChinaImages / DepositPhotos - License: DepositPhotos
Health
Evusheld
AZD7442
AstraZeneca
European Medicines Agency
Coronavirus
SARS-CoV-2
Covid-19
Friday, 25 March 2022 - 11:30
Share this:
  • facebook
  • twitter
  • linkedin
  • whatsapp
  • reddit

EMA gives green light for AstraZeneca Covid medicine

The European Medicines Agency (EMA) advised member states to approve AstraZeneca's coronavirus medicine. Adults and children over 12 years old can then receive the medication, known as Evusheld or AZD7442, with two injections containing the active substance.

Pharmaceutical company AstraZeneca previously stated that the drug reduces the risk of coronavirus symptoms or death from Covid-19, both when taken preventively and within three days of developing symptoms. A study showed that Evusheld could lower the risk of Covid-19 by 77 percent, according to the pharmaceutical. The EMA assessed this data before authorizing the product.

The product is safe to use, the EMA concluded. The side effects are generally mild. However, research into Evusheld was done before the Omicron variant of the coronavirus became dominant. Several studies in the laboratory show that the drug is less effective against this variant, according to the EMA. That is why the medicines agency is looking at whether the dose may need to be adjusted.

Evusheld consists of two monoclonal antibodies - antibodies counterfeited in the laboratory based on samples from recovering coronavirus patients. The antibodies attach to the spike proteins of the coronavirus, which makes the virus incapable of entering cells to multiply and thus unable to cause the Covid-19 disease.

Reporting by ANP

Follow us:

Latest stories

  • Record number of entries to represent Netherlands in Eurovision 2024
  • Speaking (in Dutch) about bikes & the weather: The Delft Method at NedLes
  • Twente solar car damaged ahead of World Solar Challenge race in Australia
  • New center-left coalition in The Hague presents its plans
  • Man sentenced to 5 years in prison for sextortion of dozens of underage girls
  • Sustainability plans for Amsterdam flats faltering over homeowner association fights

Top stories

  • Suspect in Rotterdam killings arraigned Wednesday; Was to be evicted before shootings
  • Gov't to compensate 3,000 families around Schiphol for noise pollution
  • Gender wage gap increases to 7.4% in Netherlands
  • Amsterdam preparing to lower speed limit to 30 kilometers per hour
  • Over €100,000 raised for Rotterdam shooting victims
  • RKC goalkeeper Etienne Vaessen regains consciousness after on-field collapse

© 2012-2023, NL Times, All rights reserved.

Footer menu

  • Privacy
  • Contact
  • Partner content